Thrombogenicity of polysaccharide-coated surfaces

被引:59
作者
Keuren, JFW
Wielders, SJH
Willems, GM
Morra, M
Cahalan, L
Cahalan, P
Lindhout, T
机构
[1] Maastricht Univ, Dept Biochem, NL-6200 MD Maastricht, Netherlands
[2] Percardia Inc, Merrimack, NH USA
[3] Nobil Bio Ric, I-14018 Villafranca Dasti, Italy
[4] Maastricht Univ, Cardiovasc Res Inst, NL-6200 MD Maastricht, Netherlands
关键词
polysaccharide coating; artificial surface; fibrinogen; platelets; thrombin and antithrombin;
D O I
10.1016/S0142-9612(02)00620-8
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Heparinization of artificial surfaces has been proven to reduce the intrinsic thrombogenicity of such surfaces. The mechanism by which immobilized heparin reduces thrombogenicity is not completely understood. In the present study heparin-, alginic acid- and chondroitin-6-sulphate-coated surfaces were examined for protein adsorption, platelet adhesion and thrombin generation. The protein-binding capacity from solutions of purified proteins was significantly higher for heparin-coated surfaces when compared with alginic acid- and chondroitin sulphate-coated surfaces. Yet, when the surfaces were exposed to flowing plasma, only the heparinized surface adsorbed significant amounts of antithrombin. None of the surfaces adsorbed fibrinogen under these conditions, and as a result no platelets adhered from flowing whole blood. Our results indicate that protein adsorption and platelet adhesion from anticoagulated blood cannot be used to assess the thrombogenicity of (coated) artificial surfaces. Indeed, the thrombin generation potentials of the different surfaces varied remarkable: while non-coated surface readily produced thrombin, alginic acid- and chondroitin sulphate-coated surfaces showed a marked reduction and virtually no thrombin was generated in flowing whole blood passing by heparinized surfaces. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1917 / 1924
页数:8
相关论文
共 35 条
[11]   Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety [J].
Hirsh, J ;
Warkentin, TE ;
Shaughnessy, SG ;
Anand, SS ;
Halperin, JL ;
Raschke, R ;
Granger, C ;
Ohman, EM ;
Dalen, JE .
CHEST, 2001, 119 (01) :64S-94S
[12]  
HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174
[13]   IMPLICATIONS OF THE 3-DIMENSIONAL STRUCTURE OF ALPHA-1-ANTITRYPSIN FOR STRUCTURE AND FUNCTION OF SERPINS [J].
HUBER, R ;
CARRELL, RW .
BIOCHEMISTRY, 1989, 28 (23) :8951-8966
[14]  
Keuren JFW, 2002, THROMB HAEMOSTASIS, V87, P742
[15]   Preparation of heparin-like surfaces by introducing sulfate and carboxylate groups on poly(ethylene) using an argon plasma treatment [J].
Lens, JP ;
Terlingen, JGA ;
Engbers, GHM ;
Feijen, J .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 1998, 9 (04) :357-372
[16]   Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor II in the presence of dermatan sulfate but not heparin [J].
Liaw, PCY ;
Becker, DL ;
Stafford, AR ;
Fredenburgh, JC ;
Weitz, JI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) :20959-20965
[17]  
LORTAT-JACOB H, 1991, CELL MOL BIOL, V37, P253
[18]  
MORRA M, 2001, WATER BIOMATERIALS S, P353
[19]   Antithrombotic activity of a fucosylated chondroitin sulphate from echinoderm: sulphated fucose branches on the polysaccharide account for its antithrombotic action [J].
Mourao, PAS ;
Guimaraes, MAM ;
Mulloy, B ;
Thomas, S ;
Gray, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (04) :647-652
[20]   Structure/function studies of anticoagulant sulphated polysaccharides using NMR [J].
Mulloy, B ;
Mourao, PAS ;
Gray, E .
JOURNAL OF BIOTECHNOLOGY, 2000, 77 (01) :123-135